Biomaterials Market Outlok 2031
The global biomaterials market size was valued at USD 39.89 Billion in 2022 and is likely reach to USD 67.39 Billion by 2031, expanding at a CAGR of 6% during the forecast period, 2023–2031. The growth of the market is attributed to the rising trend of implant devices and plastic surgery.
Biomaterials are artificially derived synthetic or natural substances that are engineered to interact with biological systems for a medical purpose to improve the functionality of damaged tissues and organs. These biomaterials are used for treatments of wound care, sports injury, and vascular surgery.
Biomaterials science can be implemented in various advanced medical technologies, such as tissue engineering, drug delivery devices, and other medical implants. Biomaterials are utilized for biomed engineering, bio mineralization, and biomolecules.
The study of biomaterials consists of elements, such as biology, medicine, chemistry, and tissue engineering. Biomaterials can be synthesized in the laboratory by using variety of chemical approaches. Metallic components such as ceramics, polymers or composite materials are used for synthesis.
Market Trends, Drivers, Restraints, and Opportunities
- Rising usage of various types of biomaterials, such as bioinert, bioactive, bioabsorbable is expected to spur the market growth during the forecast period.
- Increasing number of funds and grants by government bodies is projected to drive the market growth.
- Growing applications of biomaterials, ranging from neurology to plastic surgery is anticipated to boost the market expansion in the coming years.
- Increasing use of biomaterials in drug delivery is projected to propel the market growth during the forecast period.
- Expanding application of biomaterials can create new market avenues in the coming years.
- Stringent clinical & regulatory processes are anticipated to hamper the market growth in the coming years.
- Increasing R&D investments is expected to create lucrative opportunities for the industry players in the projected timeline.
Scope of Biomaterials Market Report:
The report on the global biomaterials market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes
|
Details
|
Report Title
|
Biomaterials Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2022
|
Historic Data
|
2016–2021
|
Forecast Period
|
2023–2031
|
Segmentation
|
Types (Natural Biomaterials, Metallic Biomaterials, Ceramic Biomaterials, and Polymeric Biomaterials), Applications (Neurology, Cardiology, Orthopedics, Ophthalmology, Wound Care, Dental, Plastic Surgery, and Others)
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
Key Players Covered in the Report
|
Koninklijke DSM N.V., Corbion NV, Biomet Inc., Noble Biomaterials, Inc., and Bayer AG.
|
Biomaterials Market Segment Insights
Polymeric biomaterial segment to account a key market share
Based on types, the biomaterials market is divided into natural biomaterials, metallic biomaterials, ceramic biomaterials, and polymeric biomaterials. The polymeric biomaterial segment is expected to constitute a large market share during the forecast period due to the broad range of product applications.
The wide availability of biopolymers and advanced polymers for bio-resorbable tissue fixation and other orthopedic applications are expected to accelerate the revenue generation of the market segment. Polymeric biomaterials are one of the key fundamental foundation of tissue engineering.
Orthopedics segment to expand at a substantial CAGR
On the basis of applications, the market is segmented into neurology, cardiology, orthopedics, ophthalmology, wound care, dental, plastic surgery and others.
The Orthopedic Biomaterials segment is anticipated to register a healthy CAGR during the forecast period. Increasing adoption of bone graft substitutes include allograft, autograft, demineralized bone matrix, bone morphogenetic proteins, cell-based matrices, and synthetic bone graft substitutes is driving the segment growth.
Bone graft substitutes are applicable in spinal fusion, trauma fixation, joint reconstruction, craniomaxillofacial fixation, and dental fixations. The technological advancements for better osteoinductivity, osteoconductivity, and osteogenicity are expected to propel the growth of the market segment.

Biomaterials Market Regional Outlook
Asia Pacific to dominate the market
In terms of regions, the biomaterials market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa.
Asia Pacific is anticipated to dominate the market during the forecast period. The regional market growth can be attributed to the increasing orthopedic procedures, dental surgeries, and cardiovascular surgeries.
High prevalence of cardiac disorders and increasing pacemaker procedures in India is expected to drive the market growth in the region. Moreover, high rate of angioplasty with stent placement is anticipated to spur the market expansion in Asia Pacific.
Segments
Types
- Natural Biomaterials
- Metallic Biomaterials
- Ceramic Biomaterials
- Polymeric Biomaterials
Applications
- Neurology
- Cardiology
- Orthopedics
- Ophthalmology
- Wound Care
- Dental
- Plastic Surgery
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
Competitive Landscape
Key players competing in the biomaterials market include Koninklijke DSM N.V., Corbion NV, Biomet Inc., Noble Biomaterials, Inc., and Bayer AG.
